Table 1 Association between plasma miR-107 levels and clinicopathological characteristics in PCa patients with pancreatectomy.

From: Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer

n

Ā 

Plasma miR-107 concentration

P-valuea

High

Low

Total

74

50

Ā 

24

Ā Ā 

Age

Ā Ā Ā Ā Ā 

0.7301

Ā <65

22

15

(30%)

7

(29%)

Ā 

Ā ā‰„65

52

35

(70%)

17

(71%)

Ā 

Sex

Ā Ā Ā Ā Ā 

0.3258

Ā Male

34

21

(42%)

13

(54%)

Ā 

Ā Female

40

29

(58%)

11

(46%)

Ā 

pT (TNM)

Ā Ā Ā Ā Ā 

0.0755

Ā T1-2

10

9

(18%)

1

(4%)

Ā 

Ā T3-4

64

41

(82%)

23

(96%)

Ā 

pN (TNM)

Ā Ā Ā Ā Ā 

0.0376

Ā N0

31

25

(50%)

6

(25%)

Ā 

Ā N1

43

25

(50%)

18

(75%)

Ā 

pM (TNM)

Ā Ā Ā Ā Ā 

0.7386

Ā M0

70

47

(94%)

23

(96%)

Ā 

Ā M1

4

3

(6%)

1

(4%)

Ā 
  1. aChi-square test. NOTE: significant values are in bold.
Back to article page